Defective adiponectin activity has also been demonstrated in chronic hepatitis C (CHC), but in this case the mechanism seems related to adiponectin resistance, leading to hyper-adiponectinemia, especially in patients with severe fibrosis [14]. The gene discussed is ADIPOQ; the disease is cryohydrocytosis.